CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 18, 2026, 4:00 PM EST
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $160.58 thousand as of August 19, 2026. Its market cap has increased by 30.27% in one year.
Market Cap
160.58K
Enterprise Value
1.32M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has decreased from 238.06K to 160.58K, a decrease of -32.55%. That is a compound annual growth rate of -2.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 160.58K | -46.70% |
| Dec 31, 2025 | 301.28K | 30.86% |
| Dec 31, 2024 | 230.22K | -47.89% |
| Dec 29, 2023 | 441.78K | -81.12% |
| Dec 30, 2022 | 2.34M | -79.95% |
| Dec 31, 2021 | 11.67M | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovation Pharmaceuticals | 264.38K |
| Regen BioPharma | 234.79K |
| Ampio Pharmaceuticals | 207.88K |
| Ocean Biomedical | 185.89K |
| Endonovo Therapeutics | 180.76K |
| GB Sciences | 158.82K |
| Affymax | 119.18K |
| Immunotech Laboratories | 114.99K |